Related Experiment Videos
Payment for drug therapy
1American Medical Association, Chicago, IL.
Physician Executive
|December 10, 1989
Summary
Healthcare technology assessment now includes drug therapy due to rising costs. This report outlines how healthcare service buyers view payment for complex drug treatments.
Area of Science:
- Health Services Research
- Healthcare Management
- Pharmaceutical Policy
Background:
- Healthcare technology encompasses more than equipment; drug therapy is increasingly complex and costly.
- Assessing the value and payment for advanced pharmaceutical treatments is a growing concern.
Purpose of the Study:
- To detail the perspectives of healthcare service buyers regarding payment for drug therapy.
- To analyze the evolving landscape of healthcare technology assessment.
Main Methods:
- Analysis of healthcare service buyer positions on drug therapy payment.
- Review of current trends in healthcare technology and pharmaceutical cost management.
Main Results:
- Healthcare buyers are evaluating drug therapy as a critical component of healthcare technology.
- The complexity and cost of drug treatments necessitate specific assessment and payment strategies.
Conclusions:
- Drug therapy assessment is integral to modern healthcare technology evaluation.
- Understanding buyer positions is crucial for navigating payment models for innovative pharmaceuticals.